2m 2m 2m 2m 2m 2m 2m
Ultragenyx Pharm (RARE)
NASDAQ
$15.17+$0.42 (+2.83%)
Price as of Oct 02, 2026 5:34 PM EDT- $1.5BMarket Cap
- -52.27%1-Year Change
- BiotechnologyIndustry
Ultragenyx Pharm (RARE)
$15.17+$0.42 (+2.83%)
RARE | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $14.75 | ||
Change | -$0.28 (-1.86%) | ||
Open | $15.03 | ||
High | $15.25 | ||
Low | $14.62 | ||
Previous Close | $15.03 | ||
Volume | 4,120,285 | ||
30-Day Average Volume | 6,988,035 | ||
1-Week Change | -0.14% | ||
1-Month Change | -42.85% | ||
1-Year Change | -52.27% | ||
3-Year Change | -58.63% | ||
5-Year Change | -83.20% | ||
Fundamentals | |||
Shares Outstanding | 98.6M | ||
Total Assets | $1.3B | ||
Market Cap | $1.5B | ||
Enterprise Value | $1.3B | ||
Period: QTR TTM FY | |||
Revenue | $112.0M | ||
Net Income | -$92.0M | ||
Free Cash Flow | -$98.0M | ||
EBIT | -$91.0M | ||
EBITDA | -$83.0M | ||
Net Working Capital | $255.0M | ||
EPS | -$0.90 | ||
Enterprise Value/EBITDA | -16 | ||
Enterprise Value/Revenue | 12 | ||
P/B | -5 | ||
P/E | -16 | ||
PEG | -0 | ||
Price/Free Cash Flow | -15 | ||
Price/Operating Cash Flow | -15 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue